SCHEMBL309038

SCHEMBL309038

O=C(O)c1cccc([N+](=O)[O-])c1Cl

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.64
DNA2 P51530 1/20 0.51
CASP6 P55212 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
GPR35 Q9HC97 1/20 0.48
CTSD P07339 1/20 0.46
DTYMK P23919 1/20 0.45
POLB P06746 1/20 0.45
SLC25A1 P53007 1/20 0.45
DHODH Q02127 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27827942 0.98 TSHR (0.62) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL7086897 0.87 TSHR (0.50) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL27287737 0.86 TSHR (0.57) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL1767333 0.85 TSHR (0.50) TSHRTDP1L3MBTL1ALDH1A1MEN1
SCHEMBL308476 0.84 TSHR (0.49) TSHRTDP1ALDH1A1MEN1KMT2A
SCHEMBL3910666 0.84 TSHR (0.53) TSHRTDP1L3MBTL1ALDH1A1MEN1
SCHEMBL29488320 0.84 TSHR (0.53) TSHRTDP1L3MBTL1ALDH1A1MEN1
SCHEMBL11329635 0.83 TSHR (0.54) TSHRCTDSP1TDP1L3MBTL1ALDH1A1
SCHEMBL8263377 0.83 TSHR (0.57) TSHRDNA2CASP6CTDSP1ALDH1A1
SCHEMBL8065104 0.83 TDP1 (0.57) TSHRCASP6TDP1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 954 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
CN-116143628-B Preparation method of nitrobenzamide 南通泰禾化工股份有限公司 2025-03-25 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-115594592-B Preparation method and application of 2-chloro-3-nitrobenzoic acid 江西天宇化工有限公司 2024-03-19 CN claimed
CN-116143628-A Preparation method of nitrobenzamide 南通泰禾化工股份有限公司 2023-05-23 CN claimed
CN-115594592-A Preparation method and application of 2-chloro-3-nitrobenzoic acid 江西天宇化工有限公司(CN) 2023-01-13 CN claimed
CN-106835327-B A kind of preparation method of the photochromic nano micron fibre of multiple bases 天津工业大学 2019-07-26 CN claimed
CN-109535081-A A kind of preparation method of Flubendazole impurity E 江苏宝众宝达药业有限公司 2019-03-29 CN claimed
CN-109448993-A Electrolyte of aluminum electrolytic capacitor and preparation method thereof 广州金立电子有限公司 2019-03-08 CN claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 US claimed
EP-0661388-A1 Chemical etchant for palladium AT&T Corp. (US) 1995-07-05 EP claimed
US-5380400-A From copper substrate, oxidant and corrosion inhibitor AT&T CORP. (US) 1995-01-10 US claimed
WO-1994027584-A2 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1994-12-08 WO claimed
US-RE34272-E Oxalic acid, a thiocyanate salt, and a nitrobenzenesulfonate salt REM CHEMICALS, INC. (US) 1993-06-08 US claimed
EP-0395815-B1 METHOD AND COMPOSITION FOR REFINEMENT OF METAL SURFACES REM CHEMICALS, INC. (US) 1993-06-02 EP claimed
EP-0395815-A1 Method and composition for refinement of metal surfaces REM CHEMICALS, INC. (US) 1990-11-07 EP claimed
US-4906327-A Method and composition for refinement of metal surfaces REM CHEMICALS, INC. (US) 1990-03-06 US claimed
US-4866204-A OXIDATION WITH METAL ACETYLACETONATES, PORPYRINS OR PHTHALOCYANINE CATALYSTS NOBEL CHEMICALS AB (SE) 1989-09-12 US claimed
US-4548791-A Thallium-containing composition for stripping palladium AMERICAN CHEMICAL & REFINING COMPANY, INC. (US) 1985-10-22 US claimed
US-3935005-A Composition and method for stripping gold and silver AMERICAN CHEMICAL & REFINING COMPANY, INCORPORATED (US) 1976-01-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS TSHR 1605/4885DNA2 4120/4885CASP6 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.